An examination of the quality of life among rural and outer metropolitan injecting drug users in NSW, Australia

References

• Bizzarri J, Rucci P, Vallotta A, Girelli M, Sbrana A, Iagher C, Dellantonio E. Dual diagnosis and quality of life in patients in treatment for opioid dependence. Substance Use & Misuse 2005; 40: 1765–1776
   PubMed Web of Science ®Google Scholar
• Brogly S, Mercier C, Bruneau J, Palepu A, Franco E. Towards more effective public health programming for injection drug users: Development and evaluation of the injection drug user quality of life scale.[erratum appears in Subst Use Misuse. 2003 Dec;38(14):2125]. Substance Use & Misuse 2003; 38(7)965–992
   PubMed Web of Science ®Google Scholar
• Dalgard O, Egeland A, Skaug K, Vilimas K, Steen T. Health-related quality of life in active injecting drug users with and without chronic hepatitis C virus infection. Hepatology 2004; 39(1)74–80
   PubMed Web of Science ®Google Scholar
• Davis M, Rhodes T, Martin A. Preventing hepatitis C: ‘Common sense’, ‘the bug’ and other perspectives from the risk narratives of people who inject drugs. Social Science and Medicine 2004; 59(9)1807–1818
   PubMed Web of Science ®Google Scholar
• Day C, Conroy E, Lowe J, Page J, Dolan K. Patterns of drug use and associated harms among rural injecting drug users: Comparisons with metropolitan injecting drug users. Australian Journal of Rural Health 2006; 14: 120–125
   PubMedGoogle Scholar
• Day C, Conroy E, Lowe J, Page J, Kimber J, Dolan K. Drug Use and Harms among Rural and Metropolitan Injecting Drug Users: Findings from the Rural Injectors' Project. National Drug and Alcohol Research Centre, University of New South Wales, Sydney 2005, Report No.:NDARC Technical Report 234
   Google Scholar
• Donoghue M, Dolan K, Stimson G. Life-style factors and social circumstances of syringe sharing in injecting drug users. British Journal of Addiction 1992; 87: 993–1003
   PubMedGoogle Scholar
• Dore G, Law M, MacDonald M, Kaldor J. Epidemiology of hepatitis C virus infection in Australia. Journal of Clinical Virology 2003; 26: 171–184
   PubMed Web of Science ®Google Scholar
• Fontana R, Hussain K, Schwartz S, Moyer C, Su G, Lok A. Emotional distress in chronic hepatitis C patients not receiving antiviral therapy. Journal of Hepatology 2002; 36: 401–407
   PubMed Web of Science ®Google Scholar
• Gallegos-Orozco JF, Fuentes AP, Gerardo Argueta J, Perez-Pruna C, Hinojosa-Becerril C, Sixtos-Alonso S, Cruz-Castellanos S, Gutierrez-Reyes G, Olivera-Martinez M, Gutierrez-Ruiz C, Kershenobich D. Health-related quality of life and depression in patients with chronic hepatitis C. Archives of Medical Research 2003; 34(2)124–129
   PubMed Web of Science ®Google Scholar
• Gifford S, O'Brien M, Bammer G, Banwell, Stoove M. Australian women's experiences of living with hepatitis C virus: Results from a cross-sectional survey. Journal of Gastroenterology and Hepatology 2003; 18: 841–850
   PubMed Web of Science ®Google Scholar
• Gifford S, O'Brien M, Smith A, Temple-Smith M, Stoove M, Mitchell D, Jolley D. Australian men's experiences of living with hepatitis C virus: Results from a cross-sectional survey. Journal of Gastroenterology and Hepatology 2005; 20: 79–86
   PubMed Web of Science ®Google Scholar
• Hubley AM, Russell LB, Palepu A. Injection drug use quality of life scale: A validation study. Health and Quality of Life Outcomes 2005; 3(43)
   PubMedGoogle Scholar
• Kimber J, Day C. Quality of life. Dealing with risk: A multidisciplinary study of injecting drug use, hepatitis C and other blood borne viruses in Australia, E Southgate, C Day, J Kimber, A Weatherall, M MacDonald, G Woodcock, S McGukin, K Dolan. ANCD Research Paper 7, Australian National Council on Drugs, Canberra 2003; 79–84
   Google Scholar
• Koch T. Life quality vs the 'quality of life': Assumptions underlying prospective quality of life instruments in health care planning. Social Science and Medicine 2000; 51: 419–427
   PubMed Web of Science ®Google Scholar
• Leplege A, Hunt S. The problem of quality of life in medicine. Journal of the American Medical Association 1997; 278(1)47–50
   PubMed Web of Science ®Google Scholar
• Leplege A, Hunt S. The problem of quality of life in medicine. JAMA 1997; 278(1)47–50
   PubMed Web of Science ®Google Scholar
• MacDonald MA, Wodak AD, Dolan KA, van Beek I, Cunningham PH, Kaldor JM. Hepatitis C virus antibody prevalence among injecting drug users at selected needle and syringe programs in Australia, 1995–1997. Medical Journal of Australia 2000; 172: 57–61
   PubMed Web of Science ®Google Scholar
• Miller ER, Hiller JE, Shaw DR. Quality of life in HCV-infection: Lack of association with ALT levels. Australian & New Zealand Journal of Public Health 2001; 25(4)355–361
   PubMed Web of Science ®Google Scholar
• Millson P, Challacombe L, Villeneuve P, Fischer B, Strike C, Myers T, Shore R, Hopkins S, Raftis S, Pearson M. Self-perceived health among Canadian opiate users. Canadian Journal of Public Health 2004; 95(2)99–103
   PubMed Web of Science ®Google Scholar
• Mozes B, Maor Y, Shmueli A. Do we know what global ratings of health-related quality of life measure?. Quality of Life Research 1999; 8: 269–273
   PubMed Web of Science ®Google Scholar
• National Centre in HIV Epidemiology and Clinical Research. Australian NSP Survey: National Data Report 2000–2004. National Centre in HIV Epidemiology and Clinical Research, University of NSW, Sydney 2005
   Google Scholar
• Rodger A, Jolley D, Thompson S, Lanigan A, Crofts N. The impact of diagnosis of hepatitis C virus on quality of life. Hepatology 1999; 30(5)1299–1301
   PubMed Web of Science ®Google Scholar
• Ryan C, White J. Health status at entry to methadone maintenance treatment using the SF-36 health survey questionnaire. Addiction 1996; 91(1)39–45
   PubMed Web of Science ®Google Scholar
• Smith K, Avis N, Assmann S. Distinguishing between quality of life and health status in quality of life research: A meta-analysis. Quality of Life Research 1999; 8: 447–459
   PubMed Web of Science ®Google Scholar
• Spiegel BM, Younossi ZM, Hays RD, Revicki D, Robbins S, Kanwal F. Impact of hepatitis C on health related quality of life: A systematic review and quantitative assessment. Hepatology 2005; 41(4)790–800
   PubMed Web of Science ®Google Scholar
• The WHOQOL Group. Development of the World Health Organisation WHOQOL-BREF quality of life assessment. Psychological Medicine 1998; 28: 551–558
   PubMed Web of Science ®Google Scholar
• Thein H, Butler T, Krahn M, Rawlinson W, Levy M, Kaldor J, Dore G. The effect of hepatitis C virus infection on health-related quality of life in prisoners. Journal of Urban Health 2006; 83(2)275–288
   PubMed Web of Science ®Google Scholar
• Zickmund S, Ho EY, Masuda M, Ippolito L, LaBrecque DR. “They treated me like a leper”. Stigmatization and the quality of life of patients with hepatitis C. Journal of General Internal Medicine 2003; 18(10)835–44
   PubMed Web of Science ®Google Scholar